|
Market Closed -
Australian S.E.
10:20:43 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.670 AUD | +11.25% |
|
+15.09% | +61.33% |
| 09-11 | PYC Therapeutics Says First Patient Dosed in Open-Label Extension of Drug Candidate Study in Polycystic Kidney Disease | MT |
| 09-04 | PYC Therapeutics Limited - Special Call |
Chart: Technical Analysis
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PYC | Delayed | |
OTC Markets
| PYCXF | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 2.57 | 2.57 | 2.49 |
| Spread/Res. | +3.89% | +3.89% | +7.23% |
| Spread/Supp. | +30.88% | +64.31% | +61.33% |
| Support | 2.04 | 1.625 | 1.655 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PYC Stock
- Charts PYC Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
